drugset

drugset / Trial / NCT04046081

A Clinical Trial to Evaluate Dichloroacetate (DCA) as a Treatment for Endometriosis-associated Pain

NCT04046081 ↗

Completed 30 enrolled University of Edinburgh Ferring Pharmaceuticals · collab University of Birmingham · collab University of Nottingham · collab

NaSingle-groupOpen-labelOther

Summary

This is a single-arm open label exploratory clinical trial to evaluate dichloroacetate (DCA) as a possible treatment for treatment of endometriosis-associated pain

Timeline

Start: 2019-11-19
Primary completion: 2021-09-30
Completion: 2021-09-30

Publications

Leow HW, Koscielniak M, Williams L, Saunders PTK, Daniels J, Doust AM, Jones MC, Ferguson GD, Bagger Y, Horne AW, Whitaker LHR. Dichloroacetate as a possible treatment for endometriosis-associated pain: a single-arm open-label exploratory clinical trial (EPiC). Pilot Feasibility Stud. 2021 Mar 12;7(1):67. doi: 10.1186/s40814-021-00797-0.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Dichloroacetate	Small molecule	6.25 mg/kg	Oral
Subject	Dichloroacetate	Small molecule	12.5 mg/kg	Oral

Indications